Showing results (351-360 of 366) with videos related to

Sort By:
Pageof 37
Circulation|November 12, 2019
Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITARasha K Al-Lamee, Matthew J Shun-Shin, James P Howard, et al.
Plos Medicine|February 22, 2022
Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort studyAmit Kaura, Adam Hartley, Vasileios Panoulas, et al.
Journal of the American College of Cardiology|June 2, 2022
Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional DataUpasana Tayal, Job A J Verdonschot, Mark R Hazebroek, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 2, 2021
Phasic flow patterns of right versus left coronary arteries in patients undergoing clinical physiological assessmentHenry Seligman, Sukhjinder S Nijjer, Tim P van de Hoef, et al.
Circulation|May 8, 2026
Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled StudyFiyyaz Ahmed-Jushuf, Michael J Foley, Shayna Chotai, et al.
Circulation|October 27, 2025
The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled StudyChristopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Circulation. Cardiovascular Interventions|August 3, 2021
Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery DiseaseChristopher A Rajkumar, Matthew Shun-Shin, Henry Seligman, et al.
Journal of the American College of Cardiology|May 17, 2024
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery DiseaseFlorentina A Simader, Christopher A Rajkumar, Michael J Foley, et al.
Lancet (London, England)|April 11, 2024
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trialMichael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Journal of the American College of Cardiology|May 7, 2025
Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results From the ORBITA-2 TrialFiyyaz Ahmed-Jushuf, Michael J Foley, Christopher A Rajkumar, et al.
Pageof 37